Effectiveness and Safety of Sitagliptin in Patients with Beta-thalassaemia Major and Diabetes Mellitus: A Case Series

Sitagliptin, a modern antidiabetic agent which is weight neutral and associated with low rate of hypoglycaemias, is being increasingly used in type 2 diabetes mellitus (DM). However, there is a paucity of data about its efficacy and safety in beta-thalassaemia major (β-TM). This retrospective case s...

Descripción completa

Detalles Bibliográficos
Autores principales: Zonoozi, Shahrzad, Barnard, Maria, Prescott, Emma, Jones, Romilla, Shah, Farrukh T, Tzoulis, Ploutarchos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224814/
https://www.ncbi.nlm.nih.gov/pubmed/28101310
http://dx.doi.org/10.4084/MJHID.2017.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224814/
https://www.ncbi.nlm.nih.gov/pubmed/28101310
http://dx.doi.org/10.4084/MJHID.2017.004

Ejemplares similares